Journal Article Video-Audio Media Ppublish 46 citations
PubMed: 34904915 DOI: 10.1080/15476286.2021.2010959
Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating gene.
RNA Biol 19(1):1-11
Authors: Shaw M Akula, Paul Bolin, Paul P Cook
Affiliations
- Department of Microbiology & Immunology (S.m. Akula), Department of Internal Medicine (P. Bolin, P.P.Cook), Brody School of Medicine at East Carolina University, Greenville, NC, USA.
Abstract
The role for circulating miRNAs as biomarkers of the COVID-19 disease remains uncertain. We analysed the circulating miRNA profile in twelve COVID-19 patients with moderate-severe disease. This analysis was conducted by performing next generation sequencing (NGS) followed by polymerase chain reaction (RT-qPCR). Compared with healthy controls, we detected significant changes in the circulating miRNA profile of COVID-19 patients. The miRNAs that were significantly altered in all the COVID-19 patients were miR-150-5p, miR-375, miR-122-5p, miR-494-3p, miR-3197, miR-4690-5p, miR-1915-3p, and miR-3652. Infection assays performed using miRNA mimics in HEK-293Â T cells determined miR-150-5p to have a crucial role in SARS-CoV-2 infection and this was based on the following data: (i) miR-150-5p mimic lowered SARS-CoV-2 infection; (ii) miR-150-5p inhibitor reversed the effects of miR-150-5p mimic on SARS-CoV-2 infection of cells; and (iii) a novel miRNA recognition element (MRE) was identified in the coding strand of SARS-CoV-2 , the expression of which could be inhibited by miR-150-5p mimic. Our findings identified crucial miRNA footprints in COVID-19 patients with moderate-severe disease. A combination of co-transfection and Western blotting experiments also determined the ability of miR-150-5p to inhibit SARS-CoV-2 infection via directly interacting with MRE in the coding strand of . Our investigation showed that a sharp decline in the miR-150-5p plasma levels in COVID-19 patients may support enhanced SARS-CoV-2 infection. Furthermore, this study provides insight into one possible mechanism by which COVID-19-induced changes to miR-150-5p levels may promote SARS-CoV-2 infection via modulating expression.
MeSH
Infections, Plasma, Molecular Biology, Rna, Cells, Genes, Sars Virus, Micrornas, High-Throughput Nucleotide Sequencing, Covid-19, Sars-Cov-2
Cited by
- Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance. Int J Biol Macromol, 2022
- Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation. Int Immunopharmacol, 2022
- Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19. Viruses, 2022
- Circulating microRNAs as emerging regulators of COVID-19. Theranostics, 2023
- MicroRNAs: Small but Key Players in Viral Infections and Immune Responses to Viral Pathogens. Biology (Basel), 2023
- Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients. Sci Rep, 2023
- Inhibition of kinin B1 receptor alleviates SARS-CoV-2-induced long-lasting cardiovascular complications. Am J Physiol Heart Circ Physiol, 2025
- In silico identification of potential miRNAs -mRNA inflammatory networks implicated in the pathogenesis of COVID-19. Hum Gene (Amst), 2023
- MicroRNAs as Potential Tools for Predicting Cancer Patients' Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells, 2022
- COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches. Cell Commun Signal, 2024
- Diagnostic predictability of serum miR-4793-3p and miR-1180-3p expression in community-acquired pneumonia. Biomark Med, 2024
- Inducible miR-150 Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by Targeting Viral Genome and Suppressor of Cytokine Signaling 1. Viruses, 2022
- The Molecular Basis of Asthma Exacerbations Triggered by Viral Infections: The Role of Specific miRNAs. Int J Mol Sci, 2025
- Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. Respir Res, 2023
- Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model. Drug Deliv Transl Res, 2022
- Host combats porcine reproductive and respiratory syndrome virus infection at non-coding RNAs level. Virulence, 2024
- Altered expression of miRNA profile in peripheral blood mononuclear cells following the third dose of inactivated COVID-19 vaccine. PeerJ, 2025
- The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection. Int J Med Sci, 2022
- Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets. Signal Transduct Target Ther, 2023
- Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype. iScience, 2022